WHC is still in active development. Read this to understand our approach.
depiction of WDEFBBTXULIOBB-UHFFFAOYSA-N.svg
tripsit

tilidine

Verificar en tripsit

isomerdesign

Ethyl rac-(1R,6S)-6-...

Verificar en isomerdesign

druglab

Tilidine

Verificar en druglab

drugmap

Tilidine

Verificar en drugmap

Data

InChI: InChI=1S/C17H23NO2/c1-4-20-16(19)17(14-10-6-5-7-11-14)13-9-8-12-15(17)18(2)3/h5-8,10-12,15H,4,9,13H2,1-3H3

Sinónimos: D08597,TILIDINE [MI],(+)-(1S,2R)-Ethyl-2-dimethylamino-1-phenyl-3-cyclohexen-1-carboxylat,TILIDINE [INN],2alpha-(Dimethylamino)-1-phenyl-3-cyclohexene-1beta-carboxylic acid ethyl ester,3-Cyclohexene-1-carboxylic acid, 2-(dimethylamino)-1-phenyl-, ethyl ester, (1R,2S)-rel-,32447-90-8, Ethyl (1RS,2SR)-2-(dimethylamino)-1-phenylcyclohex-3-enecarboxylate hydrochloride hemihydrate,Tilidate,3-CYCLOHEXENE-1-CARBOXYLIC ACID, 2-(DIMETHYLAMINO)-1-PHENYL-, ETHYL ESTER, (TRANS)-(+/-)-,Dextilidina, UNII-Y757T3419R component WHYVWQHDUOALSV-UMJMSJQKSA-N,Dextilidine,UNII-2728MV084C,Tilidate [BAN],dl-trans-Tilidine,valtran,tilidin,UNII-GY33N31E9Y,3-CYCLOHEXENE-1-CARBOXYLIC ACID, 2-(DIMETHYLAMINO)-1-PHENYL-, ETHYL ESTER,(1S-TRANS)-,DEA No. 9750,EINECS 251-048-6,EINECS 243-774-7,Ethyl rac-(1R,6S)-6-(dimethylamino)-3,6-dihydro[1,1′-biphenyl]-1(2H)-carboxylate,DTXSID9023671,3-Cyclohexene-1-carboxylic acid, 2-(dimethylamino)-1-phenyl-, ethyl ester, trans-, DTXSID70180262,(1S,2R)-(+)-ethyl-2-dimethylamino-1-phenyl-3-cyclohexen-1-carboxylate,DB13787,Dextilidine [INN],tilidate,Dextilidinum [INN-Latin],ethyl (1S,2R)-2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate,TILIDINE [WHO-DD],GY33N31E9Y,Dextilidina [INN-Spanish],CHEMBL2104560,TILIDINE, TRANS-(+)-,Valoron,Tilidin,(+)-(1S,2R)-ethyl-2-dimethylamino-1-phenyl-3-cyclohexen-1-carboxylate,(+)-Ethyl trans-2-(dimethylamino)-1-phenyl-3-cyclohexene-1-carboxylate,TILIDINE,20380-58-9,Ethyl trans-2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate,Tilidine [USAN:INN],trans-Tilidine,EINECS 257-522-9, Tilidine hydrochloride hemihydrate, 3-Cyclohexene-1-carboxylic acid, 2-(dimethylamino)-1-phenyl-, ethyl ester, hydrochloride, hydrate (2:2:1), (1R,2S)-rel-,TILIDINE, (+)-,Q421108, Tilidine hydrochloride hemihydrate [EP],Dextilidinum,(+)-tilidine,(+/-)-ETHYL TRANS-2-(DIMETHYLAMINO)-1-PHENYL-3-CYCLOHEXENE-1-CARBOXYLATE,IDS-NT-003,SCHEMBL25188,51931-66-9,2728MV084C,CHEBI:77822,valoron, 255733-17-6,Tilidine (INN),Ethyl rac-(1R,2S)-2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate

Estimated data

Solubilidad: -2.941 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 95.9% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.